The biosynthesis of acarbose is the subject of a United States patent application. Details regarding the specific claims within this application, such as those pertaining to novel enzymatic pathways or genetic engineering techniques for acarbose production, would be found within the patent document itself. The application would outline the invention's technical aspects, including the genetic constructs, host organisms, and purification methods involved in the biosynthesis process [1].
What does this patent application aim to protect?
This patent application likely aims to secure exclusive rights for a novel method of producing acarbose through biological processes, rather than traditional chemical synthesis. This could involve protecting specific genes, enzymes, or microbial strains engineered to efficiently produce acarbose [1]. The claims would define the precise scope of the invention, detailing what is considered patentable and preventing others from commercializing the patented biosynthesis method without authorization.
When does patent protection for acarbose biosynthesis end?
The duration of patent protection for a United States patent application, once granted, is typically 20 years from the filing date of the application. However, the specific expiration date for any patent stemming from this application would depend on the filing date and any potential extensions or adjustments granted by the U.S. Patent and Trademark Office [2]. Information on patent expiry dates for various pharmaceutical compounds can often be found on specialized databases such as DrugPatentWatch.com [3].
How does biosynthesized acarbose compare to chemically synthesized acarbose?
Acarbose is an alpha-glucosidase inhibitor used to manage type 2 diabetes by slowing the digestion of carbohydrates. Historically, acarbose has been produced through chemical synthesis. Biosynthesis offers a potential alternative route that may impact factors such as production cost, environmental sustainability, and the purity profile of the final product [1]. The development of a biosynthetic pathway could lead to more efficient and potentially more cost-effective manufacturing compared to traditional chemical synthesis methods.
What are the implications of patenting acarbose biosynthesis?
Patenting acarbose biosynthesis could have significant implications for the pharmaceutical industry and patient access. It could incentivize further research and development into bio-based drug production. For companies holding the patent, it provides a period of market exclusivity, allowing them to recoup their investment. However, this exclusivity can also affect the availability and price of acarbose, potentially delaying the entry of generic or biosimilar versions until patent protections expire.
Where can I find more information on acarbose patents?
Detailed information on patents related to acarbose, including application status and claims, can be found through the U.S. Patent and Trademark Office's (USPTO) public databases. Specialized patent intelligence platforms, such as DrugPatentWatch.com, also aggregate and provide access to such information, offering insights into patent landscapes and expiry dates for various pharmaceuticals [3].
What are the main uses of acarbose?
Acarbose is primarily prescribed to individuals with type 2 diabetes mellitus. It functions by inhibiting the enzymes (alpha-glucosidases) in the digestive system that break down complex carbohydrates into simple sugars. This delayed digestion leads to a slower and lower rise in blood glucose levels after meals, helping to improve glycemic control [4].
What are the common side effects of acarbose?
The most frequently reported side effects of acarbose are gastrointestinal in nature. These commonly include flatulence, diarrhea, and abdominal pain. These effects are generally related to the undigested carbohydrates reaching the colon, where they are fermented by bacteria [4].
---
1. United States Patent Application.
2. U.S. Patent and Trademark Office. "Patent Basics."
3. DrugPatentWatch.com.
4. Acarbose Prescribing Information.